Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy

AIMS: Peripartum cardiomyopathy (PPCM) is a systolic left ventricular dysfunction developing in the peripartum phase in previously healthy women. Relaxin-2 is a pregnancy hormone with potential beneficial effects in heart failure patients. We evaluated Relaxin-2 as a potential diagnostic marker and/...

詳細記述

保存先:
書誌詳細
出版年:Cardiovasc Res
主要な著者: Nonhoff, Justus, Ricke-Hoch, Melanie, Mueller, Mirco, Stapel, Britta, Pfeffer, Tobias, Kasten, Martina, Scherr, Michaela, von Kaisenberg, Constantin, Bauersachs, Johann, Haghikia, Arash, Hilfiker-Kleiner, Denise
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2017
主題:
Original Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5412020/
https://ncbi.nlm.nih.gov/pubmed/28453725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvw245
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料